Showing 6,381 - 6,400 results of 19,887 for search '"S4C"', query time: 0.15s Refine Results
  1. 6381
  2. 6382
  3. 6383
  4. 6384
  5. 6385
  6. 6386
  7. 6387
  8. 6388
  9. 6389
  10. 6390

    Application of artificial intelligence brain structure-based paradigm to predict the slip condition impact on magnetized thermal Casson viscoplastic fluid model under combined temp... by Umar Farooq, Shan Ali Khan, Haihu Liu, Muhammad Imran, Lotfi Ben Said, Aleena Ramzan, Taseer Muhammad

    Published 2025-02-01
    “…These resulting nonlinear ordinary differential equations are solved by using the bvp4c solver in MATLAB. The numerical solutions generated from the bvp4c solver for the problem under consideration are used to develop the reference dataset for the anticipated radiative Casson fluid Levenberg-Marquardt backpropagation neural network (LMT-ABPNN). …”
    Get full text
    Article
  11. 6391
  12. 6392

    Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography? by Yoko Omi, Juro Yanagida, Yusaku Yoshida, Kiyomi Horiuchi, Takahiro Okamoto

    Published 2024-04-01
    “…MLNM and lung metastases were detected in 1.2% and 3.3% of patients, respectively. cT3-4, cN1, central LN metastasis, and lateral LN metastasis were RFs for MLNM in all patients (p < 0.05, p < 0.05, p < 0.05, p < 0.01) and older patients (age: ≥55 years) (p < 0.01, p < 0.05, p < 0.05, p < 0.05). cT3-4, cN1, gross extrathyroidal extension, central LN metastasis, and lateral LN metastasis were RFs for lung metastasis in all patients (p < 0.01, p < 0.05, p < 0.01, p < 0.01, p < 0.01, respectively). cN1 and gross extrathyroidal extension, central LN metastasis, and lateral LN metastasis were RFs in older patients (p < 0.01, p < 0.01, p < 0.05, p < 0.01), while lateral LN metastasis was an RF for lung metastasis in those of <55 years of age (younger patients) (p < 0.05). …”
    Get full text
    Article
  13. 6393
  14. 6394
  15. 6395
  16. 6396
  17. 6397

    Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study by Lehana Thabane, Milos R Popovic, Kristin E Musselman, Daria O'Reilly, James M Bowen, Kim D Anderson, James R Wilson, Radha Korupolu, Jacqueline Pierce, Naaz Kapadia

    Published 2020-09-01
    “…The objective is to compare the efficacy of MyndMove therapy versus conventional therapy (CT) in improving upper extremity function in individuals with C4–C7 traumatic, incomplete spinal cord injury (SCI). …”
    Get full text
    Article
  18. 6398
  19. 6399
  20. 6400